Tumor Repressor Circular RNA as a New Target for Preventative Gene Therapy Against Doxorubicin-Induced Cardiotoxicity

Circ Res. 2020 Jul 31;127(4):483-485. doi: 10.1161/CIRCRESAHA.120.317568. Epub 2020 Jul 30.

Authors

James W S Jahng¹, Lichao Liu¹, Joseph C Wu^{1

2

3}

Affiliations

¹ From the Stanford Cardiovascular Institute (J.W.S.J., L.L., J.C.W.), Stanford University School of Medicine, CA.
² Division of Cardiovascular Medicine, Department of Medicine (J.C.W.), Stanford University School of Medicine, CA.
³ Department of Radiology (J.C.W.), Stanford University School of Medicine, CA.

No abstract available

Keywords: Editorials; cardiotoxicity; circular RNA; induced pluripotent stem cell; microRNA.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cardiotoxicity
Doxorubicin / adverse effects
Genetic Therapy
Humans
MicroRNAs*
Neoplasms*
RNA, Circular
Sirtuins*
Survivin

Substances

MIRN330 microRNA, human
MicroRNAs
RNA, Circular
Survivin
Doxorubicin
SIRT6 protein, human
Sirtuins

Grant support